A population-based study of the association between bullous pemphigoid and neurologic disorders.

[1]  M. Camilleri,et al.  Incidence of bullous pemphigoid and mortality of patients with bullous pemphigoid in Olmsted County, Minnesota, 1960 through 2009. , 2014, Journal of the American Academy of Dermatology.

[2]  F. Wojnarowska,et al.  Immunopathological characteristics of patients with bullous pemphigoid and neurological disease , 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.

[3]  B. Boeve,et al.  Incidence of dementia with Lewy bodies and Parkinson disease dementia. , 2013, JAMA neurology.

[4]  K. Taghipour,et al.  The relationship between motor neuron disease and bullous pemphigoid: an English cohort study. , 2013, Journal of the American Academy of Dermatology.

[5]  T. Nishikawa,et al.  Unilateral bullous pemphigoid without erythema and eosinophil infiltration in a hemiplegic patient , 2012, The Journal of dermatology.

[6]  B. Yawn,et al.  Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project. , 2012, Mayo Clinic proceedings.

[7]  Tzeng-Ji Chen,et al.  Comorbidity profiles among patients with bullous pemphigoid: a nationwide population‐based study , 2011, The British journal of dermatology.

[8]  L. Naldi,et al.  Mortality of bullous pemphigoid in Switzerland: a prospective study , 2011, The British journal of dermatology.

[9]  B. Yawn,et al.  American Journal of Epidemiology Practice of Epidemiology Use of a Medical Records Linkage System to Enumerate a Dynamic Population over Time: the Rochester Epidemiology Project , 2022 .

[10]  J. Roujeau,et al.  Risk factors for bullous pemphigoid in the elderly: a prospective case-control study. , 2011, The Journal of investigative dermatology.

[11]  S. Langan,et al.  The relationship between neurological disease and bullous pemphigoid: a population-based case-control study. , 2011, The Journal of investigative dermatology.

[12]  J. Britton,et al.  Autoimmune dementia: clinical course and predictors of immunotherapy response. , 2010, Mayo Clinic proceedings.

[13]  E G Tangalos,et al.  Prevalence of mild cognitive impairment is higher in men , 2010, Neurology.

[14]  Jiang Chen,et al.  Sera of Elderly Bullous Pemphigoid Patients with Associated Neurological Diseases Recognize Bullous Pemphigoid Antigens in the Human Brain , 2010, Gerontology.

[15]  L. Vaillant,et al.  Neurological Disorders in Patients with Bullous Pemphigoid , 2007, Dermatology.

[16]  A. Serwin,et al.  Epidemiological and clinical analysis of pemphigoid patients in northeastern Poland in 2000-2005. , 2007, Medical science monitor : international medical journal of experimental and clinical research.

[17]  T. Suuronen,et al.  Distribution of collagen XVII in the human brain , 2007, Brain Research.

[18]  P. Nicaise-Roland,et al.  Corrélation entre présence d’anticorps anti-antigène de type 2 de la pemphigoïde et démence chez les sujets âgés sans manifestation clinique de pemphigoïde☆ , 2006 .

[19]  I. Alafuzoff,et al.  Collagen XVII is expressed in human CNS neurons. , 2006, Matrix biology : journal of the International Society for Matrix Biology.

[20]  K. Tasanen,et al.  Collagen XVII and BPAG1 expression in the retina: Evidence for an anchoring complex in the central nervous system , 2005, The Journal of comparative neurology.

[21]  B. Crickx,et al.  Bullous pemphigoid in a leg affected with hemiparesia: a possible relation of neurological diseases with bullous pemphigoid? , 2001, European journal of dermatology : EJD.

[22]  D. Zillikens,et al.  Increased risk of bullous pemphigoid in male and very old patients: A population-based study on incidence. , 1999, Journal of the American Academy of Dermatology.

[23]  L. Vaillant,et al.  Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French Bullous Study Group. , 1998, Archives of dermatology.

[24]  J. Rossant,et al.  The mouse dystonia musculorum gene is a neural isoform of bullous pemphigoid antigen 1 , 1995, Nature Genetics.

[25]  E. Beutner,et al.  Basement zone antibodies in bullous pemphigoid. , 1967, JAMA.

[26]  F. Antonicelli,et al.  Clinical and immunologic factors associated with bullous pemphigoid relapse during the first year of treatment: a multicenter, prospective study. , 2014, JAMA dermatology.

[27]  Jun Li,et al.  Mortality of bullous pemphigoid in China. , 2013, JAMA dermatology.

[28]  A. Weaver,et al.  Anti-bullous pemphigoid 180 and 230 antibodies in a sample of unaffected subjects. , 2010, Archives of dermatology.

[29]  T. Pavlík,et al.  Bullous pemphigoid and internal diseases - A case-control study. , 2010, European journal of dermatology : EJD.

[30]  L. Puig,et al.  Bullous pemphigoid and multiple sclerosis: a report of two cases with ELISA test. , 2007, European journal of dermatology : EJD.

[31]  P. Verpillat,et al.  [Correlation between the presence of type-2 anti-pemphigoid antibodies and dementia in elderly subjects with no clinical signs of pemphigoid]. , 2006, Annales de dermatologie et de venereologie.

[32]  F. Valent,et al.  A retrospective epidemiological study on the association of bullous pemphigoid and neurological diseases. , 2005, Acta dermato-venereologica.

[33]  L. Vaillant,et al.  Incidence and Distribution of Subepidermal Autoimmune Bullous Skin Diseases in Three French Regions , 1995 .

[34]  L. Vaillant,et al.  Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group. , 1995, Archives of dermatology.